Unilab Corp.

Unilab Corp.

Unilab Corp.

Date Founded



420 East 3rd Street,Suite 202,Los Angeles, CA 90013

Type of Company


Employees (Worldwide)



Medical Support Services
Hospitals & Patient Services

Company Description

Unilab Corp. owns and operates clinical testing labs. It provides glucose, heart disease, aids, cervical cancer, osteoporosis, multiple myeloma, sexually transmitted diseases, screening, and STDs testing services. The company was founded in 1988 and is headquartered in Tarzana, CA.

Contact Data
Trying to get in touch with decision makers at Unilab Corp.? Subscribe today to access their professional contact information.
Executives & Employees

Chief Executive Officer

Account Executive

Managing Director

Senior Corporate Counsel

Vice President


Materials Analyst

Medical Doctor

Paths to Unilab Corp.
Potential Connections via
Relationship Science
Unilab Corp.
Recent Transactions
Details Hidden

Quest Diagnostics, Inc. purchases Unilab Corp.

Details Hidden

Unilab Corp. purchases FNA Clinics of America

Details Hidden

Unilab Corp. issued Common Stock

Transaction Advisors

Advised onKelso & Co. LP, UC Acquisition Sub, Inc. purchase Unilab Corp.

Investment Advisor

Advised onQuest Diagnostics, Inc. purchases Unilab Corp.

Legal Advisor

Advised onQuest Diagnostics, Inc. purchases Unilab Corp.

Legal Advisor

Advised onUnilab Corp. issued Common Stock

Advisors & Consultants
Legal Advisor

Chairman at Willkie Farr & Gallagher LLP

Legal Advisor

Partner at Willkie Farr & Gallagher LLP

Key Stats and Financials As of 2018
Market Capitalization
Total Enterprise Value
Earnings Per Share
Political Donations
Details Hidden

Kelso & Co. seeks to realize significant long-term capital gains by investing in equity, equity-related and other securities and obligations of entities undergoing LBOs and recapitalizations and that require capital for operations or business expansion. Kelso's funds primarily pursue investment opportunities in growing middle-market companies across a broad range of industries. The firm is primarily engaged in the purchase of significant ownership of businesses, including private companies, divisions or subsidiaries of public or private companies, public companies through recapitalizations or going private transactions and significant blocks of stock from public or private companies seeking equity capital or persons seeking liquidity. They focus on a variety of sectors including manufacturing, communications & media, distribution & services. consumer & retail, chemicals, healthcare, energy, textiles & apparel and transportation and logistics.Kelso generally seeks control-oriented equity investments in companies led by strong management teams that are responsible for strategic growth and day-to-day company operations. The firm may take minority stakes in companies, typically in conjunction with board representation or other significant shareholders' rights, or may join with other investors as a member of a control group. They do not engage in hostile acquisitions or substantial dismantling or liquidation of companies. Kelso is a long-term investor, typically retaining equity ownership for five to seven years. Ownership values are realized by a number of exit strategies, including public stock offering, recapitalization, sale back to the company, sale to a financial buyer and sale to a corporate buyer.